The estimated Net Worth of Robert Kramer is at least 9.75 百万$ dollars as of 8 February 2021. Mr. Kramer owns over 45,397 units of Emergent Biosolutions Inc stock worth over 1,152,230$ and over the last 18 years he sold EBS stock worth over 4,900,433$. In addition, he makes 3,693,820$ as President、 Chief Executive Officer、 Director at Emergent Biosolutions Inc.
Robert has made over 9 trades of the Emergent Biosolutions Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently he exercised 45,397 units of EBS stock worth 1,397,774$ on 8 February 2021.
The largest trade he's ever made was selling 50,189 units of Emergent Biosolutions Inc stock on 15 April 2014 worth over 1,221,600$. On average, Robert trades about 4,664 units every 56 days since 2006. As of 8 February 2021 he still owns at least 152,210 units of Emergent Biosolutions Inc stock.
You can see the complete history of Mr. Kramer stock trades at the bottom of the page.
Robert G. Kramer Sr., is re designated as President, Chief Executive Officer, Director of the Company since April 2019. He served as our president and chief operating officer from March 2018 to March 2019. Previously, he also served as our executive vice president, administration, chief financial officer and treasurer from September 2012 until his promotion to president and chief operating officer in March 2018. Mr. Kramer first joined us in 1999 as our chief financial officer. From 1999 until his prior retirement in 2010, he held various executive positions with the last being president of Emergent Biodefense Operations Lansing. Mr. Kramer returned to the company in 2011 as the interim head of the biosciences division, and then as interim executive vice president, corporate services division. Prior to joining us in 1999, Mr. Kramer held various financial management positions at Pharmaci Corporation, which subsequently merged with the Upjohn Company in 1995 and eventually became part of Pfizer Inc. Mr. Kramer holds an M.B.A. from Western Kentucky University and a B.S. in industrial management from Clemson University.
As the President、 Chief Executive Officer、 Director of Emergent Biosolutions Inc, the total compensation of Robert Kramer at Emergent Biosolutions Inc is 3,693,820$. There are no executives at Emergent Biosolutions Inc getting paid more.
Robert Kramer is 62, he's been the President、 Chief Executive Officer、 Director of Emergent Biosolutions Inc since 2019. There are 9 older and 11 younger executives at Emergent Biosolutions Inc. The oldest executive at Emergent Biosolutions Inc is Louis Sullivan, 86, who is the Independent Director.
Robert's mailing address filed with the SEC is 400 PROFESSIONAL DR, SUITE 400, , GAITHERSBURG, MD, 20879.
Over the last 18 years, insiders at Emergent Biosolutions Inc have traded over 131,382,266$ worth of Emergent Biosolutions Inc stock and bought 4,647 units worth 138,981$ . The most active insiders traders include Seamus Mulligan、Fuad El Hibri、Shahzad Malik. On average, Emergent Biosolutions Inc executives and independent directors trade stock every 21 days with the average trade being worth of 147,206$. The most recent stock trade was executed by Kathryn C Zoon on 4 June 2024, trading 10,000 units of EBS stock currently worth 61,100$.
emergent biosolutions is a global life sciences company dedicated to one simple mission—to protect and enhance life. we develop, manufacture, and deliver a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases. through our work, we envision protecting and enhancing 50 million lives with our products by 2025. additional information about the company may be found at www.emergentbiosolutions.com. follow us @emergentbiosolu and @life_at_emergent
Emergent Biosolutions Inc executives and other stock owners filed with the SEC include: